HB 2646
An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for medical policies and clinical review criteria.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill amends Pennsylvania’s Insurance Company Law of 1921 to improve quality health care accountability and protection. Specifically, it requires insurers and managed care plans to ensure that prescription drug coverage isn't restricted or delayed simply because the drug received expedited FDA approval for serious conditions. The bill focuses on clinical review criteria for medical policies.
Key provisions
- Requires insurers to not exclude prescription drugs based solely on expedited FDA approval.
- Addresses clinical review criteria for medical policies.
- Modifies Section 2154(b)(1) of the Insurance Company Law of 1921.
- Concerns quality health care accountability and protection.
- Relates to medical policies and clinical review criteria.
- Specifies the relevant FDA statute (21 U.S.C. § 356(c)).
Who is affected
- Insurance Companies
- Managed Care Plans
- Healthcare Providers
- Patients
- Pharmaceutical Companies
Notable changes
- Adds a requirement to not exclude prescription drugs based on expedited FDA approval.
- Clarifies the role of clinical review criteria in medical policy development.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Nathan Davidson
Cosponsors
Benjamin Sanchez
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours